iwAL 2022 | Immunotherapeutics in AML
Amer Zeidan, Marion Subklewe and Saar Gill
• 29 Sep 2022
In this discussion, Saar Gill, MD, PhD, University of Pennsylvania, Philadelphia, PA, Marion Subklewe, MD, Ludwig-Maximilians-University of Munich, Munich, Germany, and Amer Zeidan, MBBS, Yale University and Yale Cancer Center, New Haven, CT, discuss novel immunotherapeutic approaches being explored in acute myeloid leukemia (AML). This discussion took place at the 4th International Workshop on Acute Leukemias (iwAL), which was held in Nice, France, on 16 – 18 September 2022.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
